Clinical Program
Undisclosed (likely microbiome-linked diseases)
Pre-clinicalActive
Key Facts
Indication
Undisclosed (likely microbiome-linked diseases)
Phase
Pre-clinical
Status
Active
Company
About Notitia Biotechnologies
Notitia Biotechnologies is an early-stage biotech unlocking the therapeutic potential of the gut microbiome's 'Foundation Guild™'—a keystone group of bacteria essential for a healthy gut ecosystem. The company, which published foundational research in the journal *Cell*, is building a product pipeline that includes a Clinical Program for patients and a Wellness Program for the general public. Operating from the biotech hub of Cambridge, MA, Notitia's strategy is to translate ecological principles of the microbiome into interventions that extend the period of healthy life.
View full company profile